id	sid	eid	entity	type
ajlm-1432	1	1	n. fondoh	PERSON
ajlm-1432	1	2	cameroon department of medical laboratory sciences	ORG
ajlm-1432	1	3	catholic university of cameroon	ORG
ajlm-1432	1	4	bamenda	GPE
ajlm-1432	1	5	cameroon department of health economics	ORG
ajlm-1432	1	6	catholic university of cameroon	ORG
ajlm-1432	1	7	bamenda	GPE
ajlm-1432	1	8	cameroon	GPE
ajlm-1432	1	9	nobert ndzenjempuh department of medical laboratory sciences	ORG
ajlm-1432	1	10	catholic university of cameroon	ORG
ajlm-1432	1	11	bamenda	GPE
ajlm-1432	1	12	cameroon tamunjoh stella department	ORG
ajlm-1432	1	13	catholic university of cameroon	ORG
ajlm-1432	1	14	bamenda	GPE
ajlm-1432	1	15	cameroon	GPE
ajlm-1432	1	16	richard m. fondoh north-west	PERSON
ajlm-1432	1	17	cameroon	GPE
ajlm-1432	1	18	charles n. awasom department	PERSON
ajlm-1432	1	19	catholic university of cameroon	ORG
ajlm-1432	1	20	bamenda	GPE
ajlm-1432	1	21	cameroon	GPE
ajlm-1432	1	22	rebecca enow-tanjong	PERSON
ajlm-1432	1	23	catholic university of cameroon	ORG
ajlm-1432	1	24	bamenda	GPE
ajlm-1432	1	25	cameroon egbe	EVENT
ajlm-1432	1	26	p. egbengu department of medicine	ORG
ajlm-1432	1	27	catholic university of cameroon	ORG
ajlm-1432	1	28	bamenda	GPE
ajlm-1432	1	29	cameroon	GPE
ajlm-1432	1	30	robert leke department of medicine	ORG
ajlm-1432	1	31	catholic university of cameroon	ORG
ajlm-1432	1	32	bamenda	GPE
ajlm-1432	1	33	cameroon njini	GPE
ajlm-1432	1	34	f.n.	GPE
ajlm-1432	1	35	bamenda	GPE
ajlm-1432	1	36	cameroon	GPE
ajlm-1432	1	37	denis nsame regional hospital	PERSON
ajlm-1432	1	38	cameroon	GPE
ajlm-1432	2	1	cameroon	GPE
ajlm-1432	3	1	afr j	PERSON
ajlm-1432	4	1	2022;11(1	CARDINAL
ajlm-1432	5	1	https://doi.org/10.4102/ajlm.v11i1.1432	CARDINAL
ajlm-1432	5	2	bamenda	GPE
ajlm-1432	5	3	cameroon	GPE
ajlm-1432	5	4	n. fondoh	PERSON
ajlm-1432	5	5	nobert ndzenjempuh	PERSON
ajlm-1432	5	6	richard m. fondoh	PERSON
ajlm-1432	5	7	charles n. awasom	PERSON
ajlm-1432	5	8	rebecca enow-tanjong	PERSON
ajlm-1432	5	9	egbe p. egbengu	ORG
ajlm-1432	5	10	robert leke	PERSON
ajlm-1432	5	11	njini f.n.	ORG
ajlm-1432	5	12	denis nsame	PERSON
ajlm-1432	5	13	25	CARDINAL
ajlm-1432	5	14	oct. 2020	DATE
ajlm-1432	5	15	03 feb. 2022	CARDINAL
ajlm-1432	5	16	19	CARDINAL
ajlm-1432	6	1	2022	CARDINAL
ajlm-1432	6	2	2022	CARDINAL
ajlm-1432	10	1	haemolysin	PERSON
ajlm-1432	11	1	haemolysin	PERSON
ajlm-1432	11	2	cameroon	GPE
ajlm-1432	12	1	haemolysin	GPE
ajlm-1432	12	2	bamenda	GPE
ajlm-1432	12	3	cameroon	GPE
ajlm-1432	13	1	between june and september 2020	DATE
ajlm-1432	13	2	bamenda	GPE
ajlm-1432	13	3	cameroon	GPE
ajlm-1432	14	1	haemolysin	GPE
ajlm-1432	15	1	haemolysin	PERSON
ajlm-1432	15	2	8	CARDINAL
ajlm-1432	16	1	haemolysin	GPE
ajlm-1432	17	1	haemolysin	GPE
ajlm-1432	17	2	480	CARDINAL
ajlm-1432	17	3	52.1%	PERCENT
ajlm-1432	17	4	haemolysin	PERSON
ajlm-1432	17	5	18.5%	PERCENT
ajlm-1432	18	1	haemolysin	PERSON
ajlm-1432	19	1	haemolysin	GPE
ajlm-1432	20	1	ab recipients	ORG
ajlm-1432	21	1	haemolysin	GPE
ajlm-1432	21	2	cameroon	GPE
ajlm-1432	22	1	4 °	QUANTITY
ajlm-1432	22	2	37 °	QUANTITY
ajlm-1432	23	1	37 °	QUANTITY
ajlm-1432	24	1	non-iso	ORG
ajlm-1432	24	2	the skin,6	DATE
ajlm-1432	25	1	serotherapy	ORG
ajlm-1432	25	2	etc.).13,14,15	ORG
ajlm-1432	25	3	cameroon	GPE
ajlm-1432	25	4	51.1%	PERCENT
ajlm-1432	30	1	protocol18	WORK_OF_ART
ajlm-1432	30	2	ab recipients	ORG
ajlm-1432	30	3	ab recipients	ORG
ajlm-1432	30	4	o	DATE
ajlm-1432	30	5	côte d’ivoire	ORG
ajlm-1432	30	6	haemolysin	GPE
ajlm-1432	30	7	cameroon	GPE
ajlm-1432	31	1	cameroon	GPE
ajlm-1432	31	2	haemolysin	GPE
ajlm-1432	31	3	cameroon	GPE
ajlm-1432	32	1	the catholic university of cameroon	ORG
ajlm-1432	32	2	north-	NORP
ajlm-1432	33	1	the institutional review board	ORG
ajlm-1432	33	2	211	CARDINAL
ajlm-1432	38	1	approximately 5400	CARDINAL
ajlm-1432	38	2	about 4200	CARDINAL
ajlm-1432	38	3	yearly	DATE
ajlm-1432	39	1	africa	LOC
ajlm-1432	41	1	between june 2020	DATE
ajlm-1432	41	2	september 2020	DATE
ajlm-1432	42	1	2011	DATE
ajlm-1432	42	2	haemolysin	GPE
ajlm-1432	42	3	55.4%	PERCENT
ajlm-1432	43	1	385	CARDINAL
ajlm-1432	45	1	the three months	DATE
ajlm-1432	45	2	the last four months	DATE
ajlm-1432	45	3	at least one week	DATE
ajlm-1432	45	4	the day	DATE
ajlm-1432	45	5	24	CARDINAL
ajlm-1432	45	6	one week	DATE
ajlm-1432	46	1	greater than 50 kg	QUANTITY
ajlm-1432	46	2	between the ages of 18 and 60 years	DATE
ajlm-1432	46	3	18 and 65 years	DATE
ajlm-1432	46	4	between 100	CARDINAL
ajlm-1432	46	5	140	CARDINAL
ajlm-1432	46	6	60 mmhg	QUANTITY
ajlm-1432	46	7	100	CARDINAL
ajlm-1432	46	8	between 36 °	QUANTITY
ajlm-1432	46	9	37.5 °	QUANTITY
ajlm-1432	48	1	lewis19	ORG
ajlm-1432	49	1	tti	GPE
ajlm-1432	50	1	tti	GPE
ajlm-1432	50	2	alere medical co., ltd	ORG
ajlm-1432	50	3	matsuhidai	ORG
ajlm-1432	50	4	matsudo-shi	PERSON
ajlm-1432	50	5	chiba-ken	ORG
ajlm-1432	50	6	japan	GPE
ajlm-1432	50	7	first	ORDINAL
ajlm-1432	50	8	inc.	ORG
ajlm-1432	50	9	bethlehem	GPE
ajlm-1432	50	10	pennsylvania	GPE
ajlm-1432	50	11	united states	GPE
ajlm-1432	50	12	second	ORDINAL
ajlm-1432	50	13	jawa barat	PERSON
ajlm-1432	50	14	indonesia	GPE
ajlm-1432	51	1	rpr)-carbon	ORG
ajlm-1432	51	2	langdorp	ORG
ajlm-1432	51	3	belgium	GPE
ajlm-1432	51	4	alva	GPE
ajlm-1432	51	5	scotland	GPE
ajlm-1432	51	6	united kingdom	GPE
ajlm-1432	51	7	accessbio	GPE
ajlm-1432	51	8	somerset	GPE
ajlm-1432	51	9	new jersey	GPE
ajlm-1432	51	10	united states	GPE
ajlm-1432	52	1	two	CARDINAL
ajlm-1432	52	2	one	CARDINAL
ajlm-1432	56	1	haemolysin	PERSON
ajlm-1432	56	2	tti	ORG
ajlm-1432	56	3	haemolysin	GPE
ajlm-1432	56	4	24	CARDINAL
ajlm-1432	57	1	about 45 min	TIME
ajlm-1432	58	1	zero point 5	CARDINAL
ajlm-1432	58	2	three	CARDINAL
ajlm-1432	58	3	0.5 ml	QUANTITY
ajlm-1432	58	4	5%	PERCENT
ajlm-1432	58	5	o	DATE
ajlm-1432	60	1	37 °	QUANTITY
ajlm-1432	60	2	2	CARDINAL
ajlm-1432	62	1	2+	DATE
ajlm-1432	62	2	greater than 50%	PERCENT
ajlm-1432	62	3	3+	DATE
ajlm-1432	62	4	0.5 ml	QUANTITY
ajlm-1432	62	5	526	CARDINAL
ajlm-1432	62	6	0.5 ml	QUANTITY
ajlm-1432	62	7	5%	PERCENT
ajlm-1432	63	1	2	CARDINAL
ajlm-1432	64	1	microsoft	ORG
ajlm-1432	64	2	excel 2010	DATE
ajlm-1432	64	3	microsoft corporation	ORG
ajlm-1432	64	4	redmond	GPE
ajlm-1432	64	5	washington	GPE
ajlm-1432	64	6	united states	GPE
ajlm-1432	64	7	second	ORDINAL
ajlm-1432	65	1	social sciences	ORG
ajlm-1432	65	2	20	CARDINAL
ajlm-1432	65	3	ibm corp.	ORG
ajlm-1432	65	4	chicago	GPE
ajlm-1432	65	5	illinois	GPE
ajlm-1432	65	6	united states	GPE
ajlm-1432	66	1	haemolysin	PERSON
ajlm-1432	66	2	haemolysin	PERSON
ajlm-1432	67	1	haemolysin	PERSON
ajlm-1432	67	2	greater than 8	CARDINAL
ajlm-1432	68	1	haemolysin	PERSON
ajlm-1432	69	1	haemolysin	GPE
ajlm-1432	69	2	0.05	CARDINAL
ajlm-1432	70	1	1161	CARDINAL
ajlm-1432	70	2	june 2020	DATE
ajlm-1432	70	3	september 2020	DATE
ajlm-1432	70	4	820	CARDINAL
ajlm-1432	71	1	820	CARDINAL
ajlm-1432	71	2	812	CARDINAL
ajlm-1432	71	3	812	CARDINAL
ajlm-1432	72	1	812	CARDINAL
ajlm-1432	72	2	493	CARDINAL
ajlm-1432	72	3	o	DATE
ajlm-1432	72	4	480	CARDINAL
ajlm-1432	72	5	1	CARDINAL
ajlm-1432	73	1	1	CARDINAL
ajlm-1432	73	2	cameroon	GPE
ajlm-1432	73	3	june 2020	DATE
ajlm-1432	73	4	september 2020	DATE
ajlm-1432	74	1	between 18 years	DATE
ajlm-1432	74	2	55 years	DATE
ajlm-1432	74	3	383	CARDINAL
ajlm-1432	74	4	79.8%	PERCENT
ajlm-1432	74	5	97	CARDINAL
ajlm-1432	74	6	20.2%	PERCENT
ajlm-1432	75	1	1	CARDINAL
ajlm-1432	76	1	four hundred and sixty-three	CARDINAL
ajlm-1432	76	2	96.5%	PERCENT
ajlm-1432	76	3	17 (3.5%	PERCENT
ajlm-1432	77	1	480	CARDINAL
ajlm-1432	77	2	230	CARDINAL
ajlm-1432	77	3	250	CARDINAL
ajlm-1432	77	4	52.1%	PERCENT
ajlm-1432	78	1	haemolysins	ORG
ajlm-1432	78	2	204	CARDINAL
ajlm-1432	78	3	53.3%	PERCENT
ajlm-1432	78	4	46	DATE
ajlm-1432	78	5	47.4%	PERCENT
ajlm-1432	79	1	55 years	DATE
ajlm-1432	79	2	haemolysin	GPE
ajlm-1432	80	1	haemolysin	GPE
ajlm-1432	80	2	between 45 and 54 years	DATE
ajlm-1432	80	3	28/48	CARDINAL
ajlm-1432	80	4	58.3%	PERCENT
ajlm-1432	80	5	18–24 years	DATE
ajlm-1432	80	6	55.1%	PERCENT
ajlm-1432	80	7	35–44 years	DATE
ajlm-1432	80	8	44/87	CARDINAL
ajlm-1432	80	9	50.6%	PERCENT
ajlm-1432	80	10	25–34 years	DATE
ajlm-1432	80	11	91/188	CARDINAL
ajlm-1432	80	12	48.4%	PERCENT
ajlm-1432	81	1	haemolysin	GPE
ajlm-1432	81	2	0.304	CARDINAL
ajlm-1432	81	3	0.501	CARDINAL
ajlm-1432	82	1	two hundred and forty	CARDINAL
ajlm-1432	82	2	240	CARDINAL
ajlm-1432	82	3	463	CARDINAL
ajlm-1432	82	4	51.8%	PERCENT
ajlm-1432	82	5	10	CARDINAL
ajlm-1432	82	6	58.8%	PERCENT
ajlm-1432	82	7	17	CARDINAL
ajlm-1432	82	8	haemolysin	GPE
ajlm-1432	83	1	1	CARDINAL
ajlm-1432	83	2	haemolysin	GPE
ajlm-1432	83	3	cameroon	GPE
ajlm-1432	83	4	june 2020	DATE
ajlm-1432	83	5	september 2020	DATE
ajlm-1432	84	1	250	CARDINAL
ajlm-1432	84	2	105	CARDINAL
ajlm-1432	84	3	42.0%	PERCENT
ajlm-1432	84	4	haemolysin	GPE
ajlm-1432	84	5	69	DATE
ajlm-1432	84	6	27.6%	PERCENT
ajlm-1432	84	7	haemolysin	GPE
ajlm-1432	84	8	76	DATE
ajlm-1432	84	9	30.4%	PERCENT
ajlm-1432	84	10	2	CARDINAL
ajlm-1432	85	1	181	CARDINAL
ajlm-1432	85	2	47	CARDINAL
ajlm-1432	85	3	26.0%	PERCENT
ajlm-1432	85	4	95	CARDINAL
ajlm-1432	85	5	52.5%	PERCENT
ajlm-1432	85	6	39	CARDINAL
ajlm-1432	85	7	21.5%	PERCENT
ajlm-1432	85	8	2	CARDINAL
ajlm-1432	86	1	145	CARDINAL
ajlm-1432	86	2	haemolysin	GPE
ajlm-1432	86	3	58	DATE
ajlm-1432	86	4	40.0%	PERCENT
ajlm-1432	86	5	58	DATE
ajlm-1432	86	6	40.0%	PERCENT
ajlm-1432	86	7	29	CARDINAL
ajlm-1432	86	8	20.0%	PERCENT
ajlm-1432	87	1	haemolysin titre	WORK_OF_ART
ajlm-1432	87	2	32	DATE
ajlm-1432	87	3	five	CARDINAL
ajlm-1432	87	4	2.8%	PERCENT
ajlm-1432	87	5	three	CARDINAL
ajlm-1432	87	6	2.1%	PERCENT
ajlm-1432	87	7	haemolysin	GPE
ajlm-1432	88	1	eighty-nine	CARDINAL
ajlm-1432	88	2	18.5%	PERCENT
ajlm-1432	88	3	haemolysin	PERSON
ajlm-1432	88	4	3	CARDINAL
ajlm-1432	88	5	45	CARDINAL
ajlm-1432	88	6	50.6%	PERCENT
ajlm-1432	88	7	haemolysin	GPE
ajlm-1432	88	8	16	CARDINAL
ajlm-1432	88	9	18.0%	PERCENT
ajlm-1432	88	10	haemolysin	GPE
ajlm-1432	88	11	14	DATE
ajlm-1432	88	12	15.7%	PERCENT
ajlm-1432	88	13	haemolysin	PERSON
ajlm-1432	88	14	3	CARDINAL
ajlm-1432	89	1	2	CARDINAL
ajlm-1432	89	2	haemolysin	GPE
ajlm-1432	89	3	cameroon	GPE
ajlm-1432	89	4	june 2020	DATE
ajlm-1432	89	5	september 2020	DATE
ajlm-1432	90	1	3	CARDINAL
ajlm-1432	90	2	cameroon	GPE
ajlm-1432	90	3	june 2020	DATE
ajlm-1432	90	4	september 2020	DATE
ajlm-1432	91	1	2	CARDINAL
ajlm-1432	91	2	cameroon	GPE
ajlm-1432	91	3	june 2020	DATE
ajlm-1432	91	4	september 2020	DATE
ajlm-1432	92	1	3	CARDINAL
ajlm-1432	92	2	cameroon	GPE
ajlm-1432	92	3	june 2020	DATE
ajlm-1432	92	4	september 2020	DATE
ajlm-1432	93	1	haemolysin	GPE
ajlm-1432	94	1	52.1%	PERCENT
ajlm-1432	95	1	haemolysin	PERSON
ajlm-1432	95	2	8)	CARDINAL
ajlm-1432	95	3	18.5%	PERCENT
ajlm-1432	96	1	north-west region	LOC
ajlm-1432	96	2	haemolysin	GPE
ajlm-1432	96	3	52.8%	PERCENT
ajlm-1432	96	4	abakaliki	ORG
ajlm-1432	96	5	nigeria	GPE
ajlm-1432	96	6	2014.25	CARDINAL
ajlm-1432	96	7	haemolysin	GPE
ajlm-1432	96	8	south india	LOC
ajlm-1432	96	9	10.8%	PERCENT
ajlm-1432	96	10	2019),26	CARDINAL
ajlm-1432	96	11	abidjan	GPE
ajlm-1432	96	12	35.1%	PERCENT
ajlm-1432	96	13	2016	DATE
ajlm-1432	96	14	nigeria10	PERSON
ajlm-1432	96	15	30.3%	PERCENT
ajlm-1432	96	16	2015	DATE
ajlm-1432	96	17	22.2%	PERCENT
ajlm-1432	96	18	2015	DATE
ajlm-1432	96	19	nigeria28	GPE
ajlm-1432	96	20	16.06%	PERCENT
ajlm-1432	96	21	2015	DATE
ajlm-1432	96	22	tunisia14	GPE
ajlm-1432	96	23	6.6%	PERCENT
ajlm-1432	96	24	2008	DATE
ajlm-1432	96	25	nigeria11	ORG
ajlm-1432	96	26	23.2%	PERCENT
ajlm-1432	96	27	2001	DATE
ajlm-1432	96	28	nigeria12	PERSON
ajlm-1432	96	29	30.6%	PERCENT
ajlm-1432	96	30	1990	DATE
ajlm-1432	97	1	69.0%	PERCENT
ajlm-1432	97	2	2012	DATE
ajlm-1432	97	3	bangkok	GPE
ajlm-1432	97	4	mosquitoes.13,14,15	ORG
ajlm-1432	97	5	haemolysin	GPE
ajlm-1432	97	6	53.6%	PERCENT
ajlm-1432	97	7	2010	DATE
ajlm-1432	97	8	southeast nigeria	LOC
ajlm-1432	97	9	10.3%	PERCENT
ajlm-1432	97	10	haemolysin	GPE
ajlm-1432	97	11	8.3%	PERCENT
ajlm-1432	97	12	12.6%	PERCENT
ajlm-1432	97	13	haemolysin	PERSON
ajlm-1432	97	14	15.8%	PERCENT
ajlm-1432	97	15	32.5%	PERCENT
ajlm-1432	97	16	haemolysin	GPE
ajlm-1432	97	17	201511	DATE
ajlm-1432	97	18	lagos	GPE
ajlm-1432	97	19	nigeria	GPE
ajlm-1432	97	20	2001	DATE
ajlm-1432	97	21	ilorin	NORP
ajlm-1432	97	22	nigeria	GPE
ajlm-1432	97	23	haemolysin	PERSON
ajlm-1432	97	24	haemolysin	GPE
ajlm-1432	97	25	studies.4,10,11,14,18,31,32	GPE
ajlm-1432	97	26	haemolysin	PERSON
ajlm-1432	97	27	vivo.33	GPE
ajlm-1432	98	1	lagos	GPE
ajlm-1432	98	2	nigeria	GPE
ajlm-1432	98	3	2015	CARDINAL
ajlm-1432	98	4	18.6%)10	CARDINAL
ajlm-1432	98	5	nigeria	GPE
ajlm-1432	98	6	2021	DATE
ajlm-1432	98	7	31.7%).11	CARDINAL
ajlm-1432	98	8	location26	DATE
ajlm-1432	98	9	mosquitoes.13,14,15	ORG
ajlm-1432	99	1	haemolysin	GPE
ajlm-1432	99	2	cameroon	GPE
ajlm-1432	100	1	the ministry of public health of cameroon	ORG
ajlm-1432	100	2	cameroon	GPE
ajlm-1432	100	3	rhb	ORG
ajlm-1432	101	1	haemolysin	GPE
ajlm-1432	102	1	cameroon	GPE
ajlm-1432	102	2	haemolysin	GPE
ajlm-1432	102	3	haemolysin	GPE
ajlm-1432	105	1	cameroon	GPE
ajlm-1432	107	1	non-iso	ORG
ajlm-1432	109	1	the department of medical laboratory science	ORG
ajlm-1432	109	2	the department of health economics	ORG
ajlm-1432	109	3	catholic university of cameroon	ORG
ajlm-1432	114	1	t.s.	PERSON
ajlm-1432	118	1	n.n.	GPE
ajlm-1432	119	1	t.s.	GPE
ajlm-1432	119	2	n.n.	GPE
ajlm-1432	119	3	r.e-t.	PERSON
ajlm-1432	119	4	e.p.e.	GPE
ajlm-1432	119	5	r.l	PERSON
ajlm-1432	119	6	n.f.n.r.	GPE
ajlm-1432	120	1	d.n.	PERSON
ajlm-1432	124	1	boorman ke	PERSON
ajlm-1432	124	2	dodd	PERSON
ajlm-1432	124	3	lincoln pj	PERSON
ajlm-1432	125	1	london	GPE
ajlm-1432	125	2	churchill livingstone	PERSON
ajlm-1432	125	3	1977	DATE
ajlm-1432	126	1	lloyd e. laboratory aspects	ORG
ajlm-1432	128	1	7th	ORDINAL
ajlm-1432	128	2	edinburgh	GPE
ajlm-1432	128	3	churchill livingstone	PERSON
ajlm-1432	128	4	1991	DATE
ajlm-1432	128	5	115–124	CARDINAL
ajlm-1432	129	1	berséus o	PERSON
ajlm-1432	129	2	boman o	PERSON
ajlm-1432	129	3	nessen sc	ORG
ajlm-1432	131	1	2013;53(s1):114s–123s	CARDINAL
ajlm-1432	132	1	anne et luban	PERSON
ajlm-1432	132	2	naomi lc	PERSON
ajlm-1432	133	1	8-month-old	DATE
ajlm-1432	135	1	2004;26(4):267–269	CARDINAL
ajlm-1432	135	2	sapatnekar s	PERSON
ajlm-1432	135	3	girish s	PERSON
ajlm-1432	135	4	downes ka	PERSON
ajlm-1432	136	1	j clin apheresis	PERSON
ajlm-1432	137	1	2005;20(4):225–229	CARDINAL
ajlm-1432	138	1	suleiman am	PERSON
ajlm-1432	138	2	aisha	PERSON
ajlm-1432	145	1	ibadan	GPE
ajlm-1432	145	2	nigeria	GPE
ajlm-1432	146	1	2005	DATE
ajlm-1432	147	1	aubert ef	PERSON
ajlm-1432	147	2	boorman ke	PERSON
ajlm-1432	147	3	dodd	PERSON
ajlm-1432	149	1	659	CARDINAL
ajlm-1432	151	1	iso-agglutinin	ORG
ajlm-1432	152	1	j clin	PERSON
ajlm-1432	153	1	1946;16(3):193–206	CARDINAL
ajlm-1432	154	1	https://doi.org/10.1093/ajcp/16.3.193	ORG
ajlm-1432	154	2	anti‑b	NORP
ajlm-1432	154	3	lagos	GPE
ajlm-1432	155	1	niger j clin pract	ORG
ajlm-1432	156	1	2015;18(3):328–332	CARDINAL
ajlm-1432	158	1	afr j	PERSON
ajlm-1432	158	2	2001;30(4):319–321	ORDINAL
ajlm-1432	159	1	emeribe a.	PERSON
ajlm-1432	159	2	nigerian	NORP
ajlm-1432	160	1	east afr med	FAC
ajlm-1432	160	2	j. 1990;67(3):205–208	PERSON
ajlm-1432	160	3	uko e	PERSON
ajlm-1432	160	4	ahmed h	PERSON
ajlm-1432	161	1	sokoto	GPE
ajlm-1432	161	2	north western	NORP
ajlm-1432	162	1	med sci health	ORG
ajlm-1432	163	1	2013;1:1–8	PERSON
ajlm-1432	163	2	louati n	PERSON
ajlm-1432	163	3	ben amor	PERSON
ajlm-1432	163	4	gargouri j. recherche des hémolysines chez les donneurs de	PERSON
ajlm-1432	170	1	1996;1:13–23	CARDINAL
ajlm-1432	171	1	kagu m	PERSON
ajlm-1432	171	2	ahmed s	PERSON
ajlm-1432	171	3	askira b.	PERSON
ajlm-1432	171	4	eastern nigeria	LOC
ajlm-1432	172	1	highland med res	FAC
ajlm-1432	172	2	j. 2007;5(2):27–30	PERSON
ajlm-1432	173	1	sevidzem sl	PERSON
ajlm-1432	173	2	the university of dschang	ORG
ajlm-1432	173	3	cameroon	GPE
ajlm-1432	174	1	j. 2016;7(4	PERSON
ajlm-1432	175	1	victorine g-kap	PERSON
ajlm-1432	175	2	liliane	PERSON
ajlm-1432	176	1	abidjan	GPE
ajlm-1432	179	1	m. district	GPE
ajlm-1432	179	2	2	CARDINAL
ajlm-1432	180	1	cambridge	GPE
ajlm-1432	180	2	cambridge university press	ORG
ajlm-1432	180	3	2006	DATE
ajlm-1432	181	1	kagu m	PERSON
ajlm-1432	181	2	ahmed sg	PERSON
ajlm-1432	181	3	mohammed aa	PERSON
ajlm-1432	181	4	malah mb	PERSON
ajlm-1432	181	5	kehinde jm	PERSON
ajlm-1432	181	6	northeastern nigeria	GPE
ajlm-1432	183	1	2011;2011:302406	CARDINAL
ajlm-1432	183	2	edinoton g	GPE
ajlm-1432	183	3	gilles	PERSON
ajlm-1432	183	4	2nd	ORDINAL
ajlm-1432	184	1	london	GPE
ajlm-1432	184	2	edward arnold	PERSON
ajlm-1432	184	3	publishers) ltd;	ORG
ajlm-1432	184	4	1979	DATE
ajlm-1432	185	1	shanbhag s	PERSON
ajlm-1432	185	2	joshi s	PERSON
ajlm-1432	185	3	bhatia h.	PERSON
ajlm-1432	185	4	two	CARDINAL
ajlm-1432	186	1	1973;61(12):1824–1830	CARDINAL
ajlm-1432	187	1	veyufambom s.	PERSON
ajlm-1432	187	2	northwest region cameroon	LOC
ajlm-1432	188	1	j. 2016;15(1):390	PERSON
ajlm-1432	189	1	kamga f.	PERSON
ajlm-1432	189	2	cameroon	GPE
ajlm-1432	190	1	afr j clin exp	PERSON
ajlm-1432	191	1	abakaliki	ORG
ajlm-1432	191	2	nigeria	GPE
ajlm-1432	192	1	gjmr stud	PERSON
ajlm-1432	194	1	vijayalakshmi k.	PERSON
ajlm-1432	194	2	south india	LOC
ajlm-1432	198	1	j clin med res	PERSON
ajlm-1432	198	2	2015;3(3):42–44	TIME
ajlm-1432	199	1	nnamdi azikiwe university teaching hospital	ORG
ajlm-1432	199	2	anambra state	GPE
ajlm-1432	199	3	nigeria	GPE
ajlm-1432	200	1	orient	NORP
ajlm-1432	201	1	2015;27(1–2):34–39	CARDINAL
ajlm-1432	202	1	khampanon k	PERSON
ajlm-1432	202	2	sriwanitchrak p	ORG
ajlm-1432	203	1	ot hai	PERSON
ajlm-1432	204	1	j clin	PERSON
ajlm-1432	205	1	2012;26(4):223–226	CARDINAL
ajlm-1432	206	1	polley mj	PERSON
ajlm-1432	206	2	mollison p. serological	ORG
ajlm-1432	206	3	7s	CARDINAL
ajlm-1432	206	4	19s γ	QUANTITY
ajlm-1432	207	1	vox sanguinis	PERSON
ajlm-1432	210	1	haemolysin	GPE
ajlm-1432	210	2	calabar metropolis of nigeria	ORG
ajlm-1432	211	1	afr j biotechnol	PERSON
ajlm-1432	212	1	2007;6(10):1217–1220	TIME
ajlm-1432	213	1	adewuyi j	PERSON
ajlm-1432	213	2	gwanzura c. racial	PERSON
ajlm-1432	213	3	zimbabweans	NORP
ajlm-1432	214	1	afr j	PERSON
ajlm-1432	216	1	rudolph n	PERSON
ajlm-1432	218	1	clin exp res	ORG
ajlm-1432	219	1	1993;5(3):177–184	CARDINAL